Full history for every metric is available with a Kvantra account
Key financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SGD m | - | - | - | - | - | - | - |
| Operating profit | SGD m | - | ||||||
| Net profit | SGD m | - | - | - | - | - | - | - |
| EPS reported | SGD | - | ||||||
| Operating cashflow per share | SGD | - | ||||||
| Capex per share | SGD | - | ||||||
| FCF per share | SGD | - | ||||||
| Free cash flow | SGD m | - | ||||||
| Net debt | SGD m | - | ||||||
| Book value equity | SGD m | - | ||||||
| Book value per share | SGD | - | ||||||
| Number of shares | m | - | ||||||
| DPS (TTM paid) | SGD | - |
Financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | ||||||
| P/B LTM | x | - | ||||||
| P/S LTM | x | - | ||||||
| P/FCF LTM | x | - | ||||||
| EV/EBITDA LTM | x | - | ||||||
| EV/Sales LTM | x | - | ||||||
| Earnings Yield LTM | % | - | ||||||
| FCF Yield | % | - | ||||||
| Quality | ||||||||
| ROE | % | - | ||||||
| ROIC | % | - | ||||||
| Operating margin | % | - | ||||||
| Gross margin | % | - | ||||||
| FCF/Sales | % | - | ||||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | ||||||
| Sales Growth YoY | % | - | ||||||
| Net Income Growth YoY | % | - | ||||||
| FCF Growth | % | - | ||||||
| Operating Profit Growth | % | - | ||||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | ||||||
| Dividend Growth | % | - | ||||||
| Payout Ratio | % | - | ||||||
| FCF/Debt | x | - | ||||||
| Net Debt/EBITDA | x | - | ||||||
| EBIT/Net interest | x | - | ||||||
| Net debt/market cap | % | - | ||||||
| Net debt/Equity | x | - | ||||||
| Gross debt/equity | x | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Pharmesis International Ltd. is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The Traditional Chinese Medicine Formulated Drugs segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment includes agency products and internally manufactured products which are marketed through the distribution arm. The company was founded in 1996 and is headquartered in Singapore.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Pharmesis International Ltd. (BFK.SI)
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Pharmesis International Ltd. is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The Traditional Chinese Medicine Formulated Drugs segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment includes agency products and internally manufactured products which are marketed through the distribution arm. The company was founded in 1996 and is headquartered in Singapore.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free